This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engelmayer, J.
Right arrow Articles by Bhardwaj, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engelmayer, J.
Right arrow Articles by Bhardwaj, N.

 Previous Article  |  Next Article 

Journal of Virology, March 2001, p. 2142-2153, Vol. 75, No. 5
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.5.2142-2153.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+ and CD4+ T-Cell Responses from Chronically Infected Individuals

Jose Engelmayer,1 Marie Larsson,1 Andrew Lee,1 Marina Lee,1 William I. Cox,2 Ralph M. Steinman,1 and Nina Bhardwaj1,*

Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York,1 and Virogenetics Corporation, Troy,2 New York

Received 31 July 2000/Accepted 29 November 2000

Recombinant canarypox virus vectors containing human immunodeficiency virus type 1 (HIV-1) sequences are promising vaccine candidates, as they replicate poorly in human cells. However, when delivered intramuscularly the vaccines have induced inconsistent and in some cases transient antigen-specific cytotoxic T-cell (CTL) responses in seronegative volunteers. An attractive way to enhance these responses would be to target canarypox virus to professional antigen-presenting cells such as dendritic cells (DCs). We studied (i) the interaction between canarypox virus and DCs and (ii) the T-cell responses induced by DCs infected with canarypox virus vectors containing HIV-1 genes. Mature and not immature DCs resisted the cytopathic effects of canarypox virus and elicited strong effector CD8+ T-cell responses from chronically infected HIV+ individuals, e.g., cytolysis, and secretion of gamma interferon (IFN-gamma ) and beta -chemokines. Furthermore, canarypox virus-infected DCs were >30-fold more efficient than monocytes and induced responses that were comparable to those induced by vaccinia virus vectors or peptides. Addition of exogenous cytokines was not necessary to elicit CD8+ effector cells, although the presence of CD4+ T cells was required for their expansion and maintenance. Most strikingly, canarypox virus-infected DCs were directly able to stimulate HIV-specific, IFN-gamma -secreting CD4 helper responses from bulk as well as purified CD4+ T cells. Therefore, these results suggest that targeting canarypox virus vectors to mature DCs could potentially elicit both anti-HIV CD8+ and CD4+ helper responses in vivo.

* Corresponding author. Mailing address: The Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: (212) 327-8332. Fax: (212) 327-8875. E-mail: bhardwn{at}rockvax.rockefeller.edu.

Journal of Virology, March 2001, p. 2142-2153, Vol. 75, No. 5
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.5.2142-2153.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Van Gulck, E. R., Vanham, G., Heyndrickx, L., Coppens, S., Vereecken, K., Atkinson, D., Florence, E., Kint, I., Berneman, Z. N., Tendeloo, V. V. (2008). Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals. J. Virol. 82: 3561-3573 [Abstract] [Full Text]  
  • Van Gulck, E. R. A., Ponsaerts, P., Heyndrickx, L., Vereecken, K., Moerman, F., De Roo, A., Colebunders, R., Van den Bosch, G., Van Bockstaele, D. R., Van Tendeloo, V. F. I., Allard, S., Verrier, B., Maranon, C., Hoeffel, G., Hosmalin, A., Berneman, Z. N., Vanham, G. (2006). Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood 107: 1818-1827 [Abstract] [Full Text]  
  • O'Neill, D. W., Adams, S., Bhardwaj, N. (2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104: 2235-2246 [Abstract] [Full Text]  
  • Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Kutish, G. F., Rock, D. L. (2004). The Genome of Canarypox Virus. J. Virol. 78: 353-366 [Abstract] [Full Text]  
  • Spetz, A.-L., Sorensen, A. S., Walther-Jallow, L., Wahren, B., Andersson, J., Holmgren, L., Hinkula, J. (2002). Induction of HIV-1-Specific Immunity After Vaccination with Apoptotic HIV-1/Murine Leukemia Virus-Infected Cells. J. Immunol. 169: 5771-5779 [Abstract] [Full Text]  
  • Corinti, S., Chiarantini, L., Dominici, S., Laguardia, M. E., Magnani, M., Girolomoni, G. (2002). Erythrocytes deliver Tat to interferon-{gamma}-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro. J. Leukoc. Biol. 71: 652-658 [Abstract] [Full Text]  
  • Vacheron, S., Luther, S. A., Acha-Orbea, H. (2002). Preferential Infection of Immature Dendritic Cells and B Cells by Mouse Mammary Tumor Virus. J. Immunol. 168: 3470-3476 [Abstract] [Full Text]  
  • Foley, H. D., Otero, M., Orenstein, J. M., Pomerantz, R. J., Schnell, M. J. (2002). Rhabdovirus-Based Vectors with Human Immunodeficiency Virus Type 1 (HIV-1) Envelopes Display HIV-1-Like Tropism and Target Human Dendritic Cells. J. Virol. 76: 19-31 [Abstract] [Full Text]  
  • Parker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schulke, N., Katinger, H., Moore, J. P., Tomer, K. B. (2001). Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5. J. Virol. 75: 10906-10911 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»